Enhancing Doxorubicin Sensitivity in Osteosarcoma Cancer Cells: Unveiling the Role of Resveratrol-Induced Oxidative DNA Damage
Drug Research · 01.07.2025 · 75 (06) · 202-208
DOI: 10.1055/a-2567-9916 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Research, erschienen am 01.07.2025. Verfasst von Mohammad Reza Bazavar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, School of Medicine and Shohada Educational Hospital, Tabriz University of Medical Sciences, Tabriz, Iran. Hauptthemen laut MEDLINE: Resveratrol, Doxorubicin, Osteosarcoma, DNA Damage. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Our current research aims to investigate how Resveratrol influences DOX-induced apoptosis in Saos-2 cells resulting from DNA damage. Saos-2 cells were cultured with DOX, and an MTT assay was conducted to evaluate cell viability. The expression levels of DNA damage markers were evaluated using qRT-PCR and western blotting methods. Apoptosis was also investigated by flow cytometry. In a dose-dependent way, DOX produced a profuse suppression of cell proliferation. This study investigates the effect of Resveratrol on DOX-induced apoptosis due to DNA damage in Saos-2 cells (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, School of Medicine and Shohada Educational Hospital, Tabriz University of Medical Sciences, Tabriz, Iran.
- Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
- Department of Clinical Biochemistry and Laboratory Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
ORCID-Profile: Bahman Yousefi, Amir Valizadeh
Zitieren
APA
Bazavar, M. R., Helali, H., Boukani, L. M., Yousefi, B., & Valizadeh, A. (2025). Enhancing Doxorubicin Sensitivity in Osteosarcoma Cancer Cells: Unveiling the Role of Resveratrol-Induced Oxidative DNA Damage. Drug Research, 75(06), 202-208. https://doi.org/10.1055/a-2567-9916
Vancouver
Bazavar MR, Helali H, Boukani LM, Yousefi B, Valizadeh A. Enhancing Doxorubicin Sensitivity in Osteosarcoma Cancer Cells: Unveiling the Role of Resveratrol-Induced Oxidative DNA Damage. Drug Research. 2025;75(06):202-208. doi:10.1055/a-2567-9916
BibTeX
@article{Bazavar2025,
author = {Bazavar, Mohammad Reza and Helali, Hamed and Boukani, Linda Mohammadzadeh and Yousefi, Bahman and Valizadeh, Amir},
title = {Enhancing Doxorubicin Sensitivity in Osteosarcoma Cancer Cells: Unveiling the Role of Resveratrol-Induced Oxidative DNA Damage},
journal = {Drug Research},
year = {2025},
volume = {75},
number = {06},
pages = {202--208},
doi = {10.1055/a-2567-9916}
}
EUVIMED